Impact of non-compliance on the cost-effectiveness of pharmaceuticals

Allbwn ymchwil: Cyfraniad at gynhadleddPapur

StandardStandard

Impact of non-compliance on the cost-effectiveness of pharmaceuticals. / Hughes, D.; Hughes, D.A.
2002. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.

Allbwn ymchwil: Cyfraniad at gynhadleddPapur

HarvardHarvard

Hughes, D & Hughes, DA 2002, 'Impact of non-compliance on the cost-effectiveness of pharmaceuticals', Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium, 3/01/01.

APA

Hughes, D., & Hughes, D. A. (2002). Impact of non-compliance on the cost-effectiveness of pharmaceuticals. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.

CBE

Hughes D, Hughes DA. 2002. Impact of non-compliance on the cost-effectiveness of pharmaceuticals. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.

MLA

Hughes, D. a D.A. Hughes Impact of non-compliance on the cost-effectiveness of pharmaceuticals. 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium, 03 Ion 0001, Papur, 2002.

VancouverVancouver

Hughes D, Hughes DA. Impact of non-compliance on the cost-effectiveness of pharmaceuticals. 2002. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.

Author

Hughes, D. ; Hughes, D.A. / Impact of non-compliance on the cost-effectiveness of pharmaceuticals. Papur a gyflwynwyd yn 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium.

RIS

TY - CONF

T1 - Impact of non-compliance on the cost-effectiveness of pharmaceuticals

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2002/11/1

Y1 - 2002/11/1

M3 - Paper

T2 - 7th Low-lands mini symposium on drug exposure and compliance, Leuven, Belgium

Y2 - 3 January 0001

ER -